drugset / Trial / NCT00381719
Safety and Efficacy of AGN 203818 in Patients With Painful Diabetic Peripheral Neuropathy
RandomizedParallel-groupTriple-blindTreatment
Summary
This study will explore the safety and effectiveness of different doses of AGN 203818 in treating pain in patients with painful diabetic peripheral neuropathy
Timeline
- Start
- 2006-10
- Primary completion
- 2007-11
- Completion
- 2007-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | REZATOMIDINE | Small molecule | 3 mg | — |
| Subject | REZATOMIDINE | Small molecule | 20 mg | — |
| Subject | REZATOMIDINE | Small molecule | 60 mg | — |